Stewart Strong Takes the Helm at Q'Apel Medical
In a significant move, Q'Apel Medical has appointed Stewart Strong as its new President and Chief Executive Officer. With a wealth of expertise and a commitment to innovation, Strong is expected to guide the company in its next phase of growth.
Stewart's Vision for Q'Apel
In his new role, Stewart Strong aims to expand Q'Apel's market presence while ensuring that the company continues to provide clinical value to both physicians and patients. His focus will be on advancing the pipeline of innovations that Q'Apel is known for.
A Proven Leader
Strong is recognized as an innovation-focused leader with an impressive track record in the medical device sector. His extensive experience has positioned him to effectively lead high-performing global teams and develop commercial strategies that drive growth.
Experience That Matters
Before joining Q'Apel, Stewart Strong served as the Global President of the Hospital Business Unit at Haemonetics, where he significantly increased revenue and established a thriving global commercial organization. His experience extends across multiple roles, providing him a solid foundation for his leadership at Q'Apel.
Endorsements from Leadership
R. King Nelson, Q'Apel's Chairman of the Board, spoke highly of Strong's appointment. He expressed confidence that Strong is the right person to lead Q'Apel into a promising future, highlighting his passion for building effective teams and driving sustainable growth.
Strong's Commitment to Q'Apel's Mission
Stewart Strong emphasized his excitement about joining Q'Apel, a leader in the neurovascular space. He is eager to work with the Board of Directors and executive leadership team to advance the company’s mission and harness its full potential.
About Q'Apel Medical
Q'Apel Medical is dedicated to revolutionizing neurovascular interventions. Their customer-centric approach addresses clinical challenges that often go unmet. The team at Q'Apel is passionate about delivering high-quality, uniquely engineered products designed through collaboration with neurovascular specialists.
As an innovative force, Q'Apel Medical is committed to staying at the forefront of this essential field. Their focus on creating solutions for current and future medical needs underscores their dedication to enhancing patient care.
Media Contact Information
For media inquiries, please contact:
Charlene Herndon
SPRIG Consulting
Frequently Asked Questions
Who is Stewart Strong?
Stewart Strong is the new President and Chief Executive Officer of Q'Apel Medical, bringing over 25 years of experience in the medical device industry.
What is Q'Apel Medical known for?
Q'Apel Medical is focused on revolutionizing neurovascular interventions with innovative products designed to address current clinical challenges.
What experience does Stewart Strong have?
Prior to joining Q'Apel, Stewart was the Global President of Haemonetics' Hospital Business Unit and has held executive roles in major medical companies.
What are Stewart Strong's priorities at Q'Apel?
His primary goals include expanding the company's market presence, delivering clinical value, and advancing the innovation pipeline.
How can one learn more about Q'Apel Medical?
For more information about Q'Apel Medical, please visit their official website.
